QR Code

SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has demonstrated the value of pursuing different vaccine strategies. Vaccines based on whole viruses, a widely used vaccine technology, depend on efficient virus production. This study aimed to establish SARS-CoV-2 production...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Anna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, Rui Costa, Nandini Prabhakar Venkatesan, Xiangliang Lin, Long Van Pham, Shan Feng, Ulrik Fahnøe, Troels Kasper Høyer Scheel, Santseharay Ramirez, Udo Reichl, Jens Bukh, Yvonne Genzel, Judith Margarete Gottwein
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2021-06-01
Rangatū:Vaccines
Ngā marau:
severe acute respiratory syndrome coronavirus 2
COVID-19
scalable bioreactor
CelCradle
packed-bed
whole virus vaccine
Urunga tuihono:https://www.mdpi.com/2076-393X/9/7/706
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite